O03.1

Clinical Causes: Incomplete expulsion of pregnancy tissue after a miscarriage Development of clotting disorders like afibrinogenemia (absence of fibrinogen necessary for blood clotting) Defibrination syndrome, a condition where blood clotting factors are used up, leading to bleeding risks Hemolysis, the destruction of red blood cells, which can impair clot formation Disseminated intravascular coagulation (DIC), a serious disorder where abnormal clotting occurs throughout the body Infections or other complications that interfere with normal bleeding and clotting processes

Key Symptoms: Persistent or delayed bleeding beyond the typical timeframe for miscarriage recovery Heavy bleeding that saturates sanitary pads quickly Passing large blood clots Signs of anemia, such as fatigue or weakness Symptoms of clotting disorders, including bruising, petechiae (small purple spots), or bleeding from other sites Fever or signs of infection if infection contributes to the condition

Diagnosis Path: Doctors typically diagnose this condition through a combination of clinical evaluation and laboratory tests. Blood tests such as complete blood count (CBC), fibrinogen levels, and coagulation profiles are useful for detecting clotting anomalies. Ultrasonography may also be employed to assess the uterus for retained tissue. Monitoring bleeding patterns and overall health status helps guide diagnosis and management.

Treatment Protocols: Administering blood products such as transfusions of packed red blood cells or plasma to replace lost volume and clotting factors Use of medications to promote clotting or control bleeding, including fibrinogen concentrates if deficient Treating any underlying infections with appropriate antibiotics Close monitoring of vital signs and laboratory parameters In severe cases, surgical intervention may be necessary to remove retained tissue or control bleeding